|
0 Companies |
|
0 Products |
|
0 Products |
|
0 Mechanisms of Action |
|
1 Trial |
|
4 News |
|
- Trial completion, Enrollment change, Gene therapy: Gene Therapy ADA Deficiency (clinicaltrials.gov) - Sep 15, 2015
P1/2, N=8, Completed, Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust
Recruiting --> Completed | N=10 --> 8
- Enrollment change, Viral vector: Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector (clinicaltrials.gov) - Apr 14, 2015
P1, N=1, Completed, Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting --> Completed | N=10 --> 8 N=10 --> 1
- Trial completion, Trial primary completion date, Viral vector: Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector (clinicaltrials.gov) - Oct 10, 2014
P1, N=10, Completed, Sponsor: National Human Genome Research Institute (NHGRI)
N=10 --> 1 Recruiting --> Completed | Trial primary completion date: Mar 2016 --> Dec 2013
- New P1 trial, Viral vector: Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector (clinicaltrials.gov) - Dec 26, 2013
P1, N=10, Recruiting, Sponsor: National Human Genome Research Institute (NHGRI)